Literature DB >> 9020890

Ras activation in platelets after stimulation of the thrombin receptor, thromboxane A2 receptor or protein kinase C.

D D Shock1, K He, J D Wencel-Drake, L V Parise.   

Abstract

Several reports have indicated that the small G-protein Ras is not present immunologically in platelets. However, here we report the identification of Ras in platelets by immunoprecipitation with the Ras-specific monoclonal antibodies Y13-259 or Y13-238, followed by Western blotting. The presence of Ras was not due to contamination of samples with erythrocytes or leucocytes. Immunofluorescence studies indicated that Ras was present in a peripheral rim pattern in fixed, permeabilized platelets, suggesting an intracellular, plasma membrane location. Activation of platelets with the thrombin receptor peptide42-50, the prostaglandin H2/thromboxane A2 mimetic U46619 or phorbol 12-myristate 13-acetate induced a rapid increase in GTP-bound, activated Ras. In each case, this increase was inhibited by the protein kinase C (PKC) inhibitor bisindolylmaleimide GF 109203X, suggesting that Ras is activated downstream of PKC in platelets. Thus the activation of Ras in platelets by agonists will now allow consideration of multiple potential Ras-dependent signal transduction pathways in platelet activation processes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020890      PMCID: PMC1218100          DOI: 10.1042/bj3210525

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

Review 1.  ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues.

Authors:  A Thor; N Ohuchi; P H Hand; R Callahan; M O Weeks; C Theillet; R Lidereau; C Escot; D L Page; V Vilasi
Journal:  Lab Invest       Date:  1986-12       Impact factor: 5.662

2.  Integrin activation by R-ras.

Authors:  Z Zhang; K Vuori; H Wang; J C Reed; E Ruoslahti
Journal:  Cell       Date:  1996-04-05       Impact factor: 41.582

3.  A ras-related protein is phosphorylated and translocated by agonists that increase cAMP levels in human platelets.

Authors:  E G Lapetina; J C Lacal; B R Reep; L Molina y Vedia
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Thrombolamban, the 22-kDa platelet substrate of cyclic AMP-dependent protein kinase, is immunologically homologous with the Ras family of GTP-binding proteins.

Authors:  T E White; J C Lacal; B Reep; T H Fischer; E G Lapetina; G C White
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

6.  Expression of p21ras in normal and malignant human tissues: lack of association with proliferation and malignancy.

Authors:  P G Chesa; W J Rettig; M R Melamed; L J Old; H L Niman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family.

Authors:  M E Furth; L J Davis; B Fleurdelys; E M Scolnick
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

8.  Gn-proteins are distinct from ras p21 and other known low molecular mass GTP-binding proteins in the platelet.

Authors:  R P Bhullar; R J Haslam
Journal:  FEBS Lett       Date:  1988-09-12       Impact factor: 4.124

9.  Localization of the src gene product of the Harvey strain of MSV to plasma membrane of transformed cells by electron microscopic immunocytochemistry.

Authors:  M C Willingham; I Pastan; T Y Shih; E M Scolnick
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

10.  Small molecular weight GTP-binding proteins in human platelet membranes. Purification and characterization of a novel GTP-binding protein with a molecular weight of 22,000.

Authors:  T Ohmori; A Kikuchi; K Yamamoto; S Kim; Y Takai
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

View more
  14 in total

1.  Low-density lipoprotein activates the small GTPases Rap1 and Ral in human platelets.

Authors:  C M Hackeng; B Franke; I A Relou; G Gorter; J L Bos; H J van Rijn ; J W Akkerman
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

2.  TC21/RRas2 regulates glycoprotein VI-FcRγ-mediated platelet activation and thrombus stability.

Authors:  S Janapati; J Wurtzel; C Dangelmaier; B K Manne; D Bhavanasi; J C Kostyak; S Kim; M Holinstat; S P Kunapuli; L E Goldfinger
Journal:  J Thromb Haemost       Date:  2018-06-08       Impact factor: 5.824

3.  Activation of the small GTPase Ral in platelets.

Authors:  R M Wolthuis; B Franke; M van Triest; B Bauer; R H Cool; J H Camonis; J W Akkerman; J L Bos
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

4.  RASA3 is a critical inhibitor of RAP1-dependent platelet activation.

Authors:  Lucia Stefanini; David S Paul; Raymond F Robledo; E Ricky Chan; Todd M Getz; Robert A Campbell; Daniel O Kechele; Caterina Casari; Raymond Piatt; Kathleen M Caron; Nigel Mackman; Andrew S Weyrich; Matthew C Parrott; Yacine Boulaftali; Mark D Adams; Luanne L Peters; Wolfgang Bergmeier
Journal:  J Clin Invest       Date:  2015-02-23       Impact factor: 14.808

5.  Farnesylcysteine analogues inhibit store-regulated Ca2+ entry in human platelets: evidence for involvement of small GTP-binding proteins and actin cytoskeleton.

Authors:  J A Rosado; S O Sage
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

6.  Affinity modulation of platelet integrin alphaIIbbeta3 by beta3-endonexin, a selective binding partner of the beta3 integrin cytoplasmic tail.

Authors:  H Kashiwagi; M A Schwartz; M Eigenthaler; K A Davis; M H Ginsberg; S J Shattil
Journal:  J Cell Biol       Date:  1997-06-16       Impact factor: 10.539

Review 7.  Platelet function and Isoprostane biology. Should isoprostanes be the newest member of the orphan-ligand family?

Authors:  Harold J Ting; Fadi T Khasawneh
Journal:  J Biomed Sci       Date:  2010-04-06       Impact factor: 8.410

8.  CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets.

Authors:  Stephen M Cifuni; Denisa D Wagner; Wolfgang Bergmeier
Journal:  Blood       Date:  2008-06-10       Impact factor: 22.113

Review 9.  RAP GTPases and platelet integrin signaling.

Authors:  Lucia Stefanini; Wolfgang Bergmeier
Journal:  Platelets       Date:  2018-06-04       Impact factor: 3.862

10.  Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection.

Authors:  Anthony W Ashton; Shankar Mukherjee; F N U Nagajyothi; Huan Huang; Vicki L Braunstein; Mahalia S Desruisseaux; Stephen M Factor; Lillie Lopez; Joan W Berman; Murray Wittner; Philipp E Scherer; Valerie Capra; Thomas M Coffman; Charles N Serhan; Katherine Gotlinger; Kenneth K Wu; Louis M Weiss; Herbert B Tanowitz
Journal:  J Exp Med       Date:  2007-04-09       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.